ArticleCurrent oncology (Toronto, Ont.)2024

Impact of Adjuvant Atezolizumab on Recurrences Avoided and Treatment Cost Savings for Patients with Stage II-IIIA Non-Small Cell Lung Cancer in Canada.

Quincy Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.